SEROLOGY OF ACUTE EXACERBATION IN CHRONIC HEPATITIS-B VIRUS-INFECTION

被引:75
作者
MARUYAMA, T
IINO, S
KOIKE, K
YASUDA, K
MILICH, DR
机构
[1] SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA
[2] ST MARIANNA MED UNIV, SCH MED, INST MED SCI, KAWASAKI, KANAGAWA 213, JAPAN
[3] UNIV TOKYO, FAC MED, DEPT INTERNAL MED 1, TOKYO 113, JAPAN
关键词
D O I
10.1016/0016-5085(93)90960-K
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Liver injury in many patients with chronic hepatitis B is sporadic and is often characterized by acute exacerbations alternating with relatively normal liver function. The aim of this study was to perform detailed serological and biochemical analysis during periods of active liver disease to better understand the mechanisms responsible for the cyclic nature of liver injury. Methods: A series of serum samples from 19 hepatitis B e antigen (HBeAg)-positive patients were analyzed for alterations in serum hepatitis B virus (HBV) DNA, HBeAg, anti-HBe production, and HBeAg-specific immune complex formation before, during, and after spontaneous acute exacerbations of liver injury. Results: This analysis revealed significant correlations between increasing levels of serum HBV DNA, HBeAg, HBeAg-specific immune complexes, and liver injury. These results suggest that increases in viral replication and accumulation of viral proteins in the serum and intracellularly and the subsequent immune response play an important role in initiating acute exacerbations of liver injury in chronic hepatitis B infection. Conclusions: We propose that production of the secreted and cellular forms of the nucleoprotein reaches a threshold level and elicits specific immune responses, which mediate liver injury. © 1993.
引用
收藏
页码:1141 / 1151
页数:11
相关论文
共 33 条
[1]  
ALBERTI A, 1984, ADV HEPATITIS RES, P134
[2]  
BEASLEY RP, 1981, LANCET, V2, P1129
[3]   HLA CLASS-I-RESTRICTED HUMAN CYTOTOXIC T-CELLS RECOGNIZE ENDOGENOUSLY SYNTHESIZED HEPATITIS-B VIRUS NUCLEOCAPSID ANTIGEN [J].
BERTOLETTI, A ;
FERRARI, C ;
FIACCADORI, F ;
PENNA, A ;
MARGOLSKEE, R ;
SCHLICHT, HJ ;
FOWLER, P ;
GUILHOT, S ;
CHISARI, FV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10445-10449
[4]  
BRUNETTO MR, 1989, ITAL J GASTROENTEROL, V21, P151
[5]  
CARMAN WF, 1989, LANCET, V2, P588
[6]   REACTIVATION OF CHRONIC HEPATITIS-B VIRUS-INFECTION [J].
DAVIS, GL ;
HOOFNAGLE, JH .
GASTROENTEROLOGY, 1987, 92 (06) :2028-2031
[7]  
HOFFNAGLE JH, 1981, ANN INTERN MED, V94, P744
[8]   A SHORT COURSE OF PREDNISOLONE IN CHRONIC TYPE-B HEPATITIS - REPORT OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
HOOFNAGLE, JH ;
DAVIS, GL ;
PAPPAS, SC ;
HANSON, RG ;
PETERS, M ;
AVIGAN, MI ;
WAGGONER, JG ;
JONES, EA ;
SEEFF, LB .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (01) :12-17
[9]   CHRONIC TYPE-B HEPATITIS AND THE HEALTHY HBSAG CARRIER STATE [J].
HOOFNAGLE, JH ;
SHAFRITZ, DA ;
POPPER, H .
HEPATOLOGY, 1987, 7 (04) :758-763
[10]   REACTIVATION OF CHRONIC HEPATITIS B-VIRUS INFECTION BY CANCER-CHEMOTHERAPY [J].
HOOFNAGLE, JH ;
DUSHEIKO, GM ;
SCHAFER, DF ;
JONES, EA ;
MICETICH, KC ;
YOUNG, RC ;
COSTA, J .
ANNALS OF INTERNAL MEDICINE, 1982, 96 (04) :447-449